BioVest International, an emerging leader in active personalised immunotherapies and majority-owned subsidiary of Accentia Biopharmaceuticals, has named Dr Eduardo Sotomayor to its scientific advisory board. Dr Sotomayor currently serves as chair of the department of malignant hematology at the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida.
Welcome to Scrip
Create an account to read this article
Already a subscriber?